Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

The 2025-26 Merck Analyte Quarterly Update is Here!

Beyond Biomarkers! 

Expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker projects. Abacus dx is committed to delivering the best possible immunoassays from Merck for your research needs.

Whether you are using Merck’s industry-leading MILLIPLEX® multiplex panels to broadly survey multiple analytes, performing femtogram/mL biomarker analysis using the FemtoQuest™ ultrasensitive immunoassay platform, or examining single proteins with our tried-and-true ELISAs and RIAs, you can confidently expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker project from hypothesis to publication.

2025-26 Merck Analyte Quarterly Update

Download Here >


2025-26 Merck Analyte Quarterly Update

Download Here >

Request a Quote

Request Quote

Recent Posts

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article

Merck FemtoQuest™

Gain your desired immunoassay sensitivity with the ultrasensitive FemtoQuest™ system Measure down to femtogram/mL levels Improved precision and robust data Perform dual-plex and single analyte…

Read full article

Vector VectaMount® Mounting Media for IHC

VectaMount Mounting Medium Products When applying a coverslip, selecting the appropriate mounting medium is essential to preserve the clarity, contrast, and stability of histochemical stains…

Read full article